NERATINIB, Sindiar 2 mg cápsulas duras
GEICAM/2018-06
Phase 2 small_molecule active
Quick answer
NERATINIB, Sindiar 2 mg cápsulas duras for HER2 positive (HER2+), Hormone Receptor positive (HR+) Early-stage Breast Cancer. is a Phase 2 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- HER2 positive (HER2+), Hormone Receptor positive (HR+) Early-stage Breast Cancer.
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active